Foster & Motley Inc. Sells 2,065 Shares of Select Medical Holdings Co. (NYSE:SEM)

Foster & Motley Inc. lessened its holdings in shares of Select Medical Holdings Co. (NYSE:SEMFree Report) by 17.0% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 10,082 shares of the health services provider’s stock after selling 2,065 shares during the period. Foster & Motley Inc.’s holdings in Select Medical were worth $352,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the business. EMC Capital Management lifted its holdings in shares of Select Medical by 63.4% during the third quarter. EMC Capital Management now owns 12,536 shares of the health services provider’s stock worth $437,000 after buying an additional 4,862 shares during the last quarter. Sippican Capital Advisors boosted its holdings in Select Medical by 30.9% in the 3rd quarter. Sippican Capital Advisors now owns 12,442 shares of the health services provider’s stock valued at $434,000 after purchasing an additional 2,937 shares during the period. Mount Yale Investment Advisors LLC acquired a new stake in Select Medical in the 3rd quarter worth $193,000. Argent Capital Management LLC increased its holdings in shares of Select Medical by 28.3% during the 3rd quarter. Argent Capital Management LLC now owns 30,673 shares of the health services provider’s stock worth $1,070,000 after purchasing an additional 6,758 shares during the period. Finally, Romano Brothers AND Company raised its position in shares of Select Medical by 3.7% during the third quarter. Romano Brothers AND Company now owns 76,100 shares of the health services provider’s stock valued at $2,654,000 after buying an additional 2,700 shares during the last quarter. Institutional investors own 89.48% of the company’s stock.

Select Medical Price Performance

Shares of SEM stock opened at $38.57 on Friday. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The stock’s fifty day simple moving average is $34.41 and its 200 day simple moving average is $34.27. Select Medical Holdings Co. has a one year low of $21.56 and a one year high of $40.50. The firm has a market cap of $4.99 billion, a price-to-earnings ratio of 18.02, a P/E/G ratio of 1.90 and a beta of 1.42.

Select Medical (NYSE:SEMGet Free Report) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm’s quarterly revenue was up 5.7% on a year-over-year basis. During the same period last year, the firm posted $0.46 EPS. On average, analysts expect that Select Medical Holdings Co. will post 2.16 earnings per share for the current fiscal year.

Select Medical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th will be given a $0.125 dividend. The ex-dividend date is Wednesday, November 13th. This represents a $0.50 annualized dividend and a yield of 1.30%. Select Medical’s payout ratio is 23.36%.

Analyst Ratings Changes

Several equities analysts recently issued reports on SEM shares. StockNews.com lowered Select Medical from a “buy” rating to a “hold” rating in a research note on Tuesday. Bank of America started coverage on Select Medical in a research report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price objective on the stock. Royal Bank of Canada lifted their price target on shares of Select Medical from $40.00 to $47.00 and gave the stock an “outperform” rating in a research note on Monday. Finally, Benchmark restated a “buy” rating and issued a $48.00 price objective on shares of Select Medical in a research note on Friday, November 1st. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, Select Medical has a consensus rating of “Moderate Buy” and a consensus price target of $40.75.

Read Our Latest Stock Report on Select Medical

Select Medical Company Profile

(Free Report)

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

See Also

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.